Abstract

Several lines of evidence suggest that HAb18G/CD147 interacts with the integrin variants α3β1 and α6β1. However, the mechanism of the interaction remains largely unknown. In this study, mammalian protein-protein interaction trap (MAPPIT), a mammalian two-hybrid method, was used to study the CD147-integrin β1 subunit interaction. CD147 in human hepatocellular carcinoma (HCC) cells was interfered with by small hairpin RNA. Nude mouse xenograft model and metastatic model of HCC were used to detect the role of CD147 in carcinogenesis and metastasis. We found that the extracellular membrane-proximal domain of HAb18G/CD147 (I-type domain) binds at the metal ion-dependent adhesion site in the βA domain of the integrin β1 subunit, and Asp(179) in the I-type domain of HAb18G/CD147 plays an important role in the interaction. The levels of the proteins that act downstream of integrin, including focal adhesion kinase (FAK) and phospho-FAK, were decreased, and the cytoskeletal structures of HCC cells were rearranged bearing the HAb18G/CD147 deletion. Simultaneously, the migration and invasion capacities, secretion of matrix metalloproteinases, colony formation rate in vitro, and tumor growth and metastatic potential in vivo were decreased. These results indicate that the interaction of HAb18G/CD147 extracellular I-type domain with the integrin β1 metal ion-dependent adhesion site motif activates the downstream FAK signaling pathway, subsequently enhancing the malignant properties of HCC cells.

Highlights

  • We demonstrate that the I-type domain of HAb18G/CD147 can bind at the metal ion-dependent adhesion site (MIDAS) pocket of the ␤A domain of the integrin ␤1 subunit and that Asp179 in the I-type domain may play an important role in this binding interaction

  • Previous studies have found that CD147 interacts with the integrins ␣3␤1 and ␣6␤1 in hepatocellular carcinoma (HCC) cells and activates the downstream focal adhesion kinase (FAK)-PI3K-Ca2ϩ pathway, contributing to the enhanced invasion and metastatic potentials of HCC cells [2, 6]

  • We previously discovered that the activated FAK-paxillin and FAKPI3K-Ca2ϩ signaling pathways, which enhance the metastatic potentials of HCC cells, closely correlate with HAb18G/CD147 expression [2, 6]

Read more

Summary

Background

Results: Extracellular membrane-proximal domain of HAb18G/CD147 (I-type domain) binds at the metal ion-dependent adhesion site (MIDAS) in the ␤A domain of the integrin ␤1 subunit. We found that the extracellular membraneproximal domain of HAb18G/CD147 (I-type domain) binds at the metal ion-dependent adhesion site in the ␤A domain of the integrin ␤1 subunit, and Asp179 in the I-type domain of HAb18G/CD147 plays an important role in the interaction. The migration and invasion capacities, secretion of matrix metalloproteinases, colony formation rate in vitro, and tumor growth and metastatic potential in vivo were decreased These results indicate that the interaction of HAb18G/CD147 extracellular I-type domain with the integrin ␤1 metal ion-dependent adhesion site motif activates the downstream FAK signaling pathway, subsequently enhancing the malignant properties of HCC cells. Tumor growth potential and the invasive and metastatic potentials of HCC cells are enhanced

EXPERIMENTAL PROCEDURES
15 FLAG-CD147 16 FLAG-9F3-10F3
RESULTS
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call